These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25844750)

  • 21. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
    Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
    J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hot flashes in breast cancer survivors and men with prostate cancer.
    Stearns V
    Curr Oncol Rep; 2004 Jul; 6(4):285-90. PubMed ID: 15161582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAMS releases position statement on the treatment of vasomotor symptoms associated with menopause.
    Neff MJ
    Am Fam Physician; 2004 Jul; 70(2):393-4, 396, 399. PubMed ID: 15291096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing vasomotor symptoms in women after cancer.
    Pinkerton JV; Santen RJ
    Climacteric; 2019 Dec; 22(6):544-552. PubMed ID: 31081391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
    Buijs C; Mom CH; Willemse PH; Marike Boezen H; Maurer JM; Wymenga AN; de Jong RS; Nieboer P; de Vries EG; Mourits MJ
    Breast Cancer Res Treat; 2009 Jun; 115(3):573-80. PubMed ID: 18670875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of menopausal hot flashes.
    Tong IL
    Med Health R I; 2008 Mar; 91(3):73-6. PubMed ID: 18438096
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
    Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
    Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network.
    Newton KM; Carpenter JS; Guthrie KA; Anderson GL; Caan B; Cohen LS; Ensrud KE; Freeman EW; Joffe H; Sternfeld B; Reed SD; Sherman S; Sammel MD; Kroenke K; Larson JC; Lacroix AZ
    Menopause; 2014 Jan; 21(1):45-58. PubMed ID: 23760428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.
    Caan B; LaCroix AZ; Joffe H; Guthrie KA; Larson JC; Carpenter JS; Cohen LS; Freeman EW; Manson JE; Newton K; Reed S; Rexrode K; Shifren J; Sternfeld B; Ensrud K
    Menopause; 2015 Jun; 22(6):607-15. PubMed ID: 25405571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
    Vitolins MZ; Griffin L; Tomlinson WV; Vuky J; Adams PT; Moose D; Frizzell B; Lesser GJ; Naughton M; Radford JE; Shaw EG
    J Clin Oncol; 2013 Nov; 31(32):4092-8. PubMed ID: 24081940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment strategies for hot flushes.
    Shen W; Stearns V
    Expert Opin Pharmacother; 2009 May; 10(7):1133-44. PubMed ID: 19405789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective serotonin-reuptake inhibitors for the treatment of hot flashes.
    De Sloover Koch Y; Ernst ME
    Ann Pharmacother; 2004; 38(7-8):1293-6. PubMed ID: 15187211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
    Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
    J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons learned from the Women's Health Initiative Study.
    Mikhail N
    South Med J; 2003 Sep; 96(9):940-1. PubMed ID: 14513998
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical update: new treatments for hot flushes.
    Stearns V
    Lancet; 2007 Jun; 369(9579):2062-4. PubMed ID: 17586289
    [No Abstract]   [Full Text] [Related]  

  • 37. Menopausal symptoms after cessation of hormone replacement therapy.
    Ness J; Aronow WS; Beck G
    Maturitas; 2006 Feb; 53(3):356-61. PubMed ID: 16051451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fracture risk and SSRIs for vasomotor symptoms.
    Brown S
    Post Reprod Health; 2015 Sep; 21(3):86. PubMed ID: 26605396
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapy: nonhormonal treatment of hot flashes-a viable alternative?
    Nachtigall LE
    Nat Rev Endocrinol; 2010 Feb; 6(2):66-7. PubMed ID: 20098445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial.
    Walker EM; Rodriguez AI; Kohn B; Ball RM; Pegg J; Pocock JR; Nunez R; Peterson E; Jakary S; Levine RA
    J Clin Oncol; 2010 Feb; 28(4):634-40. PubMed ID: 20038728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.